In view of the European Commission’s forthcoming review of the Orphan Regulation, the World Orphan Drug Congress host a workshop on the key issues, which will be addressed in the forthcoming review.
The workshop is designed so that it offers the opportunity for the European Commission and relevant stakeholders to explore what revisions are needed for the legislation to appropriately incentivise the development and availability of products for people living with rare diseases.
Our Managing Partner, Christian Jervelund, participates in the workshop, introducing initial study findings.
The workshop takes place virtually on Monday 2 November from 14.00 – 17.00.
For further information, please contact Managing Partner Christian Jervelund